+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Phosphorodiamidate Morpholino Oligomers Market - Global Forecast 2026-2032- Product Image
Phosphorodiamidate Morpholino Oligomers Market - Global Forecast 2026-2032- Product Image
New

Phosphorodiamidate Morpholino Oligomers Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 190 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6120182
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior leaders navigating the evolving landscape of oligonucleotide therapeutics are increasingly integrating the Phosphorodiamidate Morpholino Oligomers Market into strategic planning. As this space accelerates, new standards in manufacturing, delivery, and supply chain management are shaping competitive advantage and operational excellence.

Market Snapshot: Phosphorodiamidate Morpholino Oligomers Market

The Phosphorodiamidate Morpholino Oligomers Market grew from USD 183.22 million in 2025 to USD 207.21 million in 2026, demonstrating robust expansion. With an expected CAGR of 14.18%, the market is on track to reach a value of USD 463.70 million by 2032. This momentum reflects escalating clinical adoption, mature manufacturing processes, and the broadening scope of PMO applications in genetic and infectious disease therapeutics.

Scope & Segmentation

The report provides a comprehensive analysis of the Phosphorodiamidate Morpholino Oligomers Market across dimensions critical for commercial, operational, and R&D strategy formulation. Key segmentation includes:

  • Product Types: Unconjugated PMOs; conjugated formats such as peptide-conjugated PMOs.
  • Applications: Therapeutic programs (spanning exon skipping, splice correction, and genetic disorders); research use; infectious disease preparedness; functional genomics.
  • End Users: Pharmaceutical and biotechnology firms requiring GMP-grade supply and regulatory support; academic and research institutes prioritizing adaptability and transparency; contract research and manufacturing organizations serving as both customers and enablers.
  • Routes of Administration: Systemic and localized delivery pathways, each with distinct implications for dose optimization, formulation, and patient access.
  • Workflow Stages: From early discovery and preclinical development to clinical execution and commercialization, with value emphasis shifting from custom design to scalable repeatability as programs mature.
  • Geographic Regions: Americas, EMEA (Europe, Middle East & Africa), and Asia-Pacific, each offering unique strengths in regulatory readiness, manufacturing, and translational infrastructure.
  • Technologies: Platforms spanning sequence-specific design, analytical comparability, delivery innovation, and industrialized manufacturing processes.

Key Takeaways

  • PMOs are transitioning from specialized research tools to scalable therapeutic platforms, supported by improved delivery methods and industrial-grade manufacturing discipline.
  • Advances in peptide-conjugated and next-generation delivery strategies are increasing PMO potency and tissue targeting, though also raising scrutiny on safety and impurity management.
  • The market is seeing enhanced collaboration models, with innovators and CDMOs forming deeper partnerships and integrating technology transfer to support global launches.
  • Segment value shifts as programs move through development, with increasing demand for platform quality systems, analytical rigor, and lifecycle oversight as products approach clinical stages.
  • Regional operational strategies must align with regulatory differences, supply-chain resilience, and documentation requirements to realize commercial success across diverse markets.

Tariff Impact: United States, 2025

Recent tariffs introduced in the United States are reshaping PMO supply chains by introducing cost pressures and qualification requirements for key inputs. These changes are prompting developers to adopt dual-sourcing, refine supplier quality management, and enhance logistics planning to mitigate delay and compliance risks. Tariff-driven pressures reinforce the importance of sourcing governance, documentation alignment, and risk modeling in procurement operations.

Research Methodology & Data Sources

Insights are grounded in a hybrid approach: structured secondary analysis of published technical and regulatory literature, and primary interviews with cross-functional experts in therapy development, manufacturing, and procurement. This triangulated methodology ensures accuracy and real-world relevance for decision-making.

Why This Report Matters

  • Identifies actionable strategies for integrating PMO platforms, delivery optimization, and quality systems to reduce operational risk and improve speed-to-clinic.
  • Enables stakeholders to anticipate market and regulatory shifts by examining tariff impacts, regional dynamics, and emerging partnership models.
  • Offers granular segmentation insights, informing investment, sourcing, and clinical planning decisions across the PMO lifecycle.

Conclusion

The Phosphorodiamidate Morpholino Oligomers Market is evolving rapidly, demanding coordinated excellence in delivery science, scalable operations, and supply resilience. Stakeholders equipped with the insights from this report will be positioned to drive measurable impact across development, commercialization, and patient outcomes.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Phosphorodiamidate Morpholino Oligomers Market, by Application
8.1. Genetic Disorders
8.1.1. Dmd
8.1.2. Sma
8.2. Infectious Diseases
8.2.1. Bacterial Infections
8.2.2. Viral Infections
8.3. Oncology
8.3.1. Breast Cancer
8.3.2. Lung Cancer
9. Phosphorodiamidate Morpholino Oligomers Market, by Delivery Modality
9.1. Lipid Conjugated
9.1.1. Cholesterol
9.1.2. Docosanyl
9.2. Peptide Conjugated
9.2.1. Penetratin
9.2.2. Tat
9.3. Unconjugated
10. Phosphorodiamidate Morpholino Oligomers Market, by End User
10.1. Contract Research Organizations
10.2. Hospitals And Clinics
10.3. Pharmaceuticals And Biotech Companies
10.4. Research Institutes
11. Phosphorodiamidate Morpholino Oligomers Market, by Formulation
11.1. Liquid
11.2. Lyophilized Powder
12. Phosphorodiamidate Morpholino Oligomers Market, by Distribution Channel
12.1. Offline
12.2. Online
13. Phosphorodiamidate Morpholino Oligomers Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Phosphorodiamidate Morpholino Oligomers Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Phosphorodiamidate Morpholino Oligomers Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Phosphorodiamidate Morpholino Oligomers Market
17. China Phosphorodiamidate Morpholino Oligomers Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Aurigene Pharmaceutical Services Pvt. Ltd.
18.6. Aurobindo Pharma Ltd.
18.7. Avidity Biosciences, Inc.
18.8. BioMarin Pharmaceutical Inc.
18.9. Biosynth AG
18.10. BOC Sciences, Inc.
18.11. Creative Biogene Corporation
18.12. Dr. Reddy’s Laboratories Ltd.
18.13. Dyne Therapeutics, Inc.
18.14. Eurofins Genomics, LLC
18.15. Gene Link, Inc.
18.16. Gene Tools, LLC
18.17. GenElixir, Inc.
18.18. Inciton, Inc.
18.19. IntegrateRNA
18.20. Nippon Shinyaku Co., Ltd.
18.21. NS Pharma, Inc.
18.22. Sarepta Therapeutics, Inc.
18.23. Sun Pharmaceutical Industries Ltd.
18.24. Valence Labs, Inc.
List of Figures
FIGURE 1. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DELIVERY MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY GENETIC DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY GENETIC DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY GENETIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DMD, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DMD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DMD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY SMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY SMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY SMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY BACTERIAL INFECTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY BACTERIAL INFECTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY BACTERIAL INFECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY VIRAL INFECTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY VIRAL INFECTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY VIRAL INFECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY BREAST CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY BREAST CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LUNG CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LUNG CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DELIVERY MODALITY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LIPID CONJUGATED, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LIPID CONJUGATED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LIPID CONJUGATED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LIPID CONJUGATED, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY CHOLESTEROL, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY CHOLESTEROL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY CHOLESTEROL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DOCOSANYL, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DOCOSANYL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DOCOSANYL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY PEPTIDE CONJUGATED, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY PEPTIDE CONJUGATED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY PEPTIDE CONJUGATED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY PEPTIDE CONJUGATED, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY PENETRATIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY PENETRATIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY PENETRATIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY TAT, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY TAT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY TAT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY UNCONJUGATED, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY UNCONJUGATED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY UNCONJUGATED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY PHARMACEUTICALS AND BIOTECH COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY PHARMACEUTICALS AND BIOTECH COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY PHARMACEUTICALS AND BIOTECH COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LYOPHILIZED POWDER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LYOPHILIZED POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. AMERICAS PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 86. AMERICAS PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 87. AMERICAS PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY GENETIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 88. AMERICAS PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 89. AMERICAS PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 90. AMERICAS PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DELIVERY MODALITY, 2018-2032 (USD MILLION)
TABLE 91. AMERICAS PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LIPID CONJUGATED, 2018-2032 (USD MILLION)
TABLE 92. AMERICAS PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY PEPTIDE CONJUGATED, 2018-2032 (USD MILLION)
TABLE 93. AMERICAS PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 94. AMERICAS PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 95. AMERICAS PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 96. NORTH AMERICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. NORTH AMERICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 98. NORTH AMERICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY GENETIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 99. NORTH AMERICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 100. NORTH AMERICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 101. NORTH AMERICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DELIVERY MODALITY, 2018-2032 (USD MILLION)
TABLE 102. NORTH AMERICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LIPID CONJUGATED, 2018-2032 (USD MILLION)
TABLE 103. NORTH AMERICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY PEPTIDE CONJUGATED, 2018-2032 (USD MILLION)
TABLE 104. NORTH AMERICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 105. NORTH AMERICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 106. NORTH AMERICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 107. LATIN AMERICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. LATIN AMERICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 109. LATIN AMERICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY GENETIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 110. LATIN AMERICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 111. LATIN AMERICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 112. LATIN AMERICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DELIVERY MODALITY, 2018-2032 (USD MILLION)
TABLE 113. LATIN AMERICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LIPID CONJUGATED, 2018-2032 (USD MILLION)
TABLE 114. LATIN AMERICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY PEPTIDE CONJUGATED, 2018-2032 (USD MILLION)
TABLE 115. LATIN AMERICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 116. LATIN AMERICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 117. LATIN AMERICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY GENETIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DELIVERY MODALITY, 2018-2032 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LIPID CONJUGATED, 2018-2032 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY PEPTIDE CONJUGATED, 2018-2032 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 129. EUROPE PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. EUROPE PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 131. EUROPE PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY GENETIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 132. EUROPE PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 133. EUROPE PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 134. EUROPE PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DELIVERY MODALITY, 2018-2032 (USD MILLION)
TABLE 135. EUROPE PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LIPID CONJUGATED, 2018-2032 (USD MILLION)
TABLE 136. EUROPE PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY PEPTIDE CONJUGATED, 2018-2032 (USD MILLION)
TABLE 137. EUROPE PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 138. EUROPE PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 139. EUROPE PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 140. MIDDLE EAST PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. MIDDLE EAST PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 142. MIDDLE EAST PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY GENETIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 143. MIDDLE EAST PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 144. MIDDLE EAST PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 145. MIDDLE EAST PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DELIVERY MODALITY, 2018-2032 (USD MILLION)
TABLE 146. MIDDLE EAST PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LIPID CONJUGATED, 2018-2032 (USD MILLION)
TABLE 147. MIDDLE EAST PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY PEPTIDE CONJUGATED, 2018-2032 (USD MILLION)
TABLE 148. MIDDLE EAST PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 149. MIDDLE EAST PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 150. MIDDLE EAST PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 151. AFRICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 152. AFRICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 153. AFRICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY GENETIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 154. AFRICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 155. AFRICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 156. AFRICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DELIVERY MODALITY, 2018-2032 (USD MILLION)
TABLE 157. AFRICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LIPID CONJUGATED, 2018-2032 (USD MILLION)
TABLE 158. AFRICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY PEPTIDE CONJUGATED, 2018-2032 (USD MILLION)
TABLE 159. AFRICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 160. AFRICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 161. AFRICA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 162. ASIA-PACIFIC PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. ASIA-PACIFIC PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 164. ASIA-PACIFIC PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY GENETIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 165. ASIA-PACIFIC PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 166. ASIA-PACIFIC PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 167. ASIA-PACIFIC PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DELIVERY MODALITY, 2018-2032 (USD MILLION)
TABLE 168. ASIA-PACIFIC PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LIPID CONJUGATED, 2018-2032 (USD MILLION)
TABLE 169. ASIA-PACIFIC PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY PEPTIDE CONJUGATED, 2018-2032 (USD MILLION)
TABLE 170. ASIA-PACIFIC PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 171. ASIA-PACIFIC PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 172. ASIA-PACIFIC PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 173. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 174. ASEAN PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 175. ASEAN PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 176. ASEAN PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY GENETIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 177. ASEAN PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 178. ASEAN PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 179. ASEAN PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DELIVERY MODALITY, 2018-2032 (USD MILLION)
TABLE 180. ASEAN PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LIPID CONJUGATED, 2018-2032 (USD MILLION)
TABLE 181. ASEAN PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY PEPTIDE CONJUGATED, 2018-2032 (USD MILLION)
TABLE 182. ASEAN PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 183. ASEAN PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 184. ASEAN PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 185. GCC PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 186. GCC PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 187. GCC PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY GENETIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 188. GCC PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 189. GCC PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 190. GCC PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DELIVERY MODALITY, 2018-2032 (USD MILLION)
TABLE 191. GCC PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LIPID CONJUGATED, 2018-2032 (USD MILLION)
TABLE 192. GCC PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY PEPTIDE CONJUGATED, 2018-2032 (USD MILLION)
TABLE 193. GCC PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 194. GCC PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 195. GCC PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 196. EUROPEAN UNION PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 197. EUROPEAN UNION PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 198. EUROPEAN UNION PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY GENETIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 199. EUROPEAN UNION PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 200. EUROPEAN UNION PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 201. EUROPEAN UNION PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DELIVERY MODALITY, 2018-2032 (USD MILLION)
TABLE 202. EUROPEAN UNION PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LIPID CONJUGATED, 2018-2032 (USD MILLION)
TABLE 203. EUROPEAN UNION PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY PEPTIDE CONJUGATED, 2018-2032 (USD MILLION)
TABLE 204. EUROPEAN UNION PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 205. EUROPEAN UNION PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 206. EUROPEAN UNION PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 207. BRICS PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 208. BRICS PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 209. BRICS PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY GENETIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 210. BRICS PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 211. BRICS PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 212. BRICS PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DELIVERY MODALITY, 2018-2032 (USD MILLION)
TABLE 213. BRICS PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LIPID CONJUGATED, 2018-2032 (USD MILLION)
TABLE 214. BRICS PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY PEPTIDE CONJUGATED, 2018-2032 (USD MILLION)
TABLE 215. BRICS PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 216. BRICS PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 217. BRICS PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 218. G7 PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 219. G7 PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 220. G7 PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY GENETIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 221. G7 PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 222. G7 PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 223. G7 PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DELIVERY MODALITY, 2018-2032 (USD MILLION)
TABLE 224. G7 PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LIPID CONJUGATED, 2018-2032 (USD MILLION)
TABLE 225. G7 PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY PEPTIDE CONJUGATED, 2018-2032 (USD MILLION)
TABLE 226. G7 PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 227. G7 PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 228. G7 PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 229. NATO PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 230. NATO PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 231. NATO PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY GENETIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 232. NATO PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 233. NATO PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 234. NATO PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DELIVERY MODALITY, 2018-2032 (USD MILLION)
TABLE 235. NATO PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LIPID CONJUGATED, 2018-2032 (USD MILLION)
TABLE 236. NATO PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY PEPTIDE CONJUGATED, 2018-2032 (USD MILLION)
TABLE 237. NATO PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 238. NATO PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 239. NATO PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 240. GLOBAL PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 241. UNITED STATES PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 242. UNITED STATES PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 243. UNITED STATES PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY GENETIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 244. UNITED STATES PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 245. UNITED STATES PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 246. UNITED STATES PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DELIVERY MODALITY, 2018-2032 (USD MILLION)
TABLE 247. UNITED STATES PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LIPID CONJUGATED, 2018-2032 (USD MILLION)
TABLE 248. UNITED STATES PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY PEPTIDE CONJUGATED, 2018-2032 (USD MILLION)
TABLE 249. UNITED STATES PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 250. UNITED STATES PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 251. UNITED STATES PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 252. CHINA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 253. CHINA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 254. CHINA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY GENETIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 255. CHINA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 256. CHINA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 257. CHINA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DELIVERY MODALITY, 2018-2032 (USD MILLION)
TABLE 258. CHINA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY LIPID CONJUGATED, 2018-2032 (USD MILLION)
TABLE 259. CHINA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY PEPTIDE CONJUGATED, 2018-2032 (USD MILLION)
TABLE 260. CHINA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 261. CHINA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 262. CHINA PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Phosphorodiamidate Morpholino Oligomers market report include:
  • Aurigene Pharmaceutical Services Pvt. Ltd.
  • Aurobindo Pharma Ltd.
  • Avidity Biosciences, Inc.
  • BioMarin Pharmaceutical Inc.
  • Biosynth AG
  • BOC Sciences, Inc.
  • Creative Biogene Corporation
  • Dr. Reddy’s Laboratories Ltd.
  • Dyne Therapeutics, Inc.
  • Eurofins Genomics, LLC
  • Gene Link, Inc.
  • Gene Tools, LLC
  • GenElixir, Inc.
  • Inciton, Inc.
  • IntegrateRNA
  • Nippon Shinyaku Co., Ltd.
  • NS Pharma, Inc.
  • Sarepta Therapeutics, Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Valence Labs, Inc.

Table Information

Report AttributeDetails
No. of Pages190
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 207.21 Million
Forecasted Market Value ( USD ) by 2032 $ 463.7 Million
Compound Annual Growth Rate14.1%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Reports

Duchenne Muscular Dystrophy Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Duchenne Muscular Dystrophy Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 115 Pages
  • Global
From
Cell Penetrating Peptide -PMO Conjugate Market - Global Forecast 2026-2032 - Product Image

Cell Penetrating Peptide -PMO Conjugate Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
PMO Drug Market - Global Forecast 2025-2030 - Product Image

PMO Drug Market - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Duchenne Muscular Dystrophy Drugs Global Market Report 2025 - Product Image

Duchenne Muscular Dystrophy Drugs Global Market Report 2025

  • Report
  • 250 Pages
  • Global
From
(4-Aminophenyl)(Morpholino)-Methanone (CAS 51207-86-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

(4-Aminophenyl)(Morpholino)-Methanone (CAS 51207-86-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.